Zn-II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism
Erin J McAllum, Blaine R Roberts, James L Hickey, Theresa N Dang, Alexandra Grubman, Paul S Donnelly, Jeffrey R Liddell, Anthony R White, Peter J Crouch
NEUROBIOLOGY OF DISEASE | ACADEMIC PRESS INC ELSEVIER SCIENCE | Published : 2015
Awarded by National Health and Medical Research Council
Awarded by Australian Research Council
Data for the vehicle treated mice presented in this study have been published previously (McAllum et al., 2013) and have been reproduced with permission from the publisher Informa Healthcare. Data for the Zn<SUP>II</SUP>(atsm) treated mice presented in this study were collected from a single study that involved the vehicle treated and Cu<SUP>II</SUP>(atsm) treated mice as described (McAllum et al., 2013). The research was supported by funds from the National Health and Medical Research Council (1005651 and 1061550), the Australian Research Council (DP110101368), and the University of Melbourne.